01-Dec-2016
Video
(1)
Image
(1)
IBM Watson Health and Pfizer: Collaborating to Accelerate Immuno-oncology Research

- Collaboration combines IBM Watson’s cognitive computing capabilities with Pfizer’s scientific knowledge to help scientists generate meaningful insights 

IBM Watson Health and Pfizer Inc. today announced a collaboration that will utilize IBM Watson for Drug Discovery to help accelerate Pfizer’s research in immuno-oncology, an approach to cancer treatment that uses the body’s immune system to help fight cancer. Pfizer is one of the first organizations worldwide to deploy Watson for Drug Discovery, and the first to customize the cloud-based cognitive tool – tapping in to Watson’s machine learning, natural language processing, and other cognitive reasoning technologies to support the identification of new drug targets, combination therapies for study, and patient selection strategies in immuno-oncology.

High Definition broadcast quality video is available for download.
Standard-Definition broadcast quality video is available for download in PAL & NTSC.
Streaming quality video is available for download as WMV,Quicktime or FLV.
Production quality audio files are available for download.
Production quality print images are available for download.
YouTube videos are also associated with this article.
Flickr images are also associated with this article.

Sorry

This content is no longer available.

It may have expired or been deleted.

Sorry

This content is no longer available.

It may have expired or been deleted.

For More Information
More Images From flickr
This is an RSS feed intended to be viewed in newsreader or syndicated to another site
SUBSCRIBE:
XML
...or click the icons below and to subscribe to this feed via the following web based newsreaders.